Fragment size and dynamics of EGFR-mutated tumor-derived DNA provide prognostic information regarding EGFR-TKI efficacy in patients with EGFR-mutated NSCLC
Kei Kunimasa(Kobe University), Fumio Imamura(Osaka International Cancer Institute)
Cited by 0
Related Papers
Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2008|365
Usefulness of ultrathin bronchoscopy in diagnosis of lung cancer
|Lung Cancer|2004|58
Glucose metabolism‐targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor‐induced drug‐tolerant persisters
|Cancer Science|2017|37